All Stories

  1. Effects of intensive lifestyle intervention and gastric bypass on aortic stiffness: A 1‐year nonrandomized clinical study

    Article • Obesity, August 2014, Wiley

    Professor Jøran Hjelmesæth, Dr Espen Gjevestad

  2. Validation of a Portable Monitor for the Diagnosis of Obstructive Sleep Apnea in Morbidly Obese Patients

    Article • Journal of Clinical Sleep Medicine, July 2014, American Academy of Sleep Medicine (AASM)

    Professor Jøran Hjelmesæth

  3. Parental marital status and childhood overweight and obesity in Norway: a nationally representative cross-sectional study

    Article • BMJ Open, June 2014, BMJ

    Professor Jøran Hjelmesæth

  4. Association of body mass index with risk of acute myocardial infarction and mortality in Norwegian male and female patients with suspected stable angina pectoris: a prospective cohort study

    Article • BMC Cardiovascular Disorders, May 2014, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  5. Randomiserte studier – nyttige for hvem?

    Article • Tidsskrift for Den norske legeforening, January 2014, Norwegian Medical Association

    Professor Jøran Hjelmesæth

  6. Effectiveness of a Cognitive Behavioral Therapy for Dysfunctional Eating among Patients Admitted for Bariatric Surgery: A Randomized Controlled Trial

    Article • Journal of Obesity, January 2014, Hindawi Publishing Corporation

    Professor Jøran Hjelmesæth

  7. Moral challenges with surgical treatment of type 2 diabetes

    Article • Journal of Diabetes and its Complications, November 2013, Elsevier

    Professor Jøran Hjelmesæth

  8. Adiposity among children in Norway by urbanity and maternal education: a nationally representative study

    Article • BMC Public Health, September 2013, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  9. The diagnostic accuracy of pocket-size cardiac ultrasound performed by unselected residents with minimal training

    Article • The International Journal of Cardiovascular Imaging, August 2013, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  10. Pulmonary function and blood gases after gastric bypass and lifestyle intervention: a comparative study

    Article • Clinical Obesity, July 2013, Wiley

    Professor Jøran Hjelmesæth

  11. Obstructive Sleep Apnea after Weight Loss: A Clinical Trial Comparing Gastric Bypass and Intensive Lifestyle Intervention

    Article • Journal of Clinical Sleep Medicine, May 2013, American Academy of Sleep Medicine (AASM)

    Professor Jøran Hjelmesæth

  12. De novo 19p13.2 microdeletion encompassing the insulin receptor and resistin genes in a patient with obesity and learning disability

    Article • American Journal of Medical Genetics Part A, May 2013, Wiley

    Professor Jøran Hjelmesæth

  13. Arterial stiffness, lifestyle intervention and a low‐calorie diet in morbidly obese patients—A nonrandomized clinical trial

    Article • Obesity, April 2013, Wiley

    Professor Jøran Hjelmesæth

  14. Impact of instrument error on the estimated prevalence of overweight and obesity in population-based surveys

    Article • BMC Public Health, February 2013, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  15. The effectiveness of secondary and tertiary care lifestyle intervention in morbidly obese patients: a 1‐year non‐randomized controlled pragmatic clinical trial

    Article • Clinical Obesity, February 2013, Wiley

    Professor Jøran Hjelmesæth

  16. Tren deg slank – en myte?

    Article • Tidsskrift for Den norske legeforening, January 2013, Norwegian Medical Association

    Professor Jøran Hjelmesæth

  17. Tidsskriftet bør stille strengere krav til litteratursøk

    Article • Tidsskrift for Den norske legeforening, January 2013, Norwegian Medical Association

    Professor Jøran Hjelmesæth

  18. Predictors of weight loss after an intensive lifestyle intervention program in obese patients: a 1-year prospective cohort study

    Article • Health and Quality of Life Outcomes, January 2013, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  19. Health related quality of life after gastric bypass or intensive lifestyle intervention: a controlled clinical study

    Article • Health and Quality of Life Outcomes, January 2013, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  20. Impact of OATP1B1, MDR1, and CYP3A4 Expression in Liver and Intestine on Interpatient Pharmacokinetic Variability of Atorvastatin in Obese Subjects

    Article • Clinical Pharmacology & Therapeutics, December 2012, Wiley

    Professor Jøran Hjelmesæth

  21. Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatin

    Article • Surgical Endoscopy, December 2012, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  22. Dietary changes in obese patients undergoing gastric bypass or lifestyle intervention: a clinical trial

    Article • British Journal Of Nutrition, October 2012, Cambridge University Press

    Professor Jøran Hjelmesæth

  23. Early Posttransplantation Hyperglycemia in Kidney Transplant Recipients Is Associated With Overall Long-term Graft Losses

    Article • Transplantation, October 2012, Wolters Kluwer Health

    Professor Jøran Hjelmesæth

  24. A controlled clinical trial of the effect of gastric bypass surgery and intensive lifestyle intervention on nocturnal hypertension and the circadian blood pressure rhythm in patients with morbid obesity

    Article • Surgery, May 2012, Elsevier

    Professor Jøran Hjelmesæth

  25. New-Onset Diabetes After Kidney Transplantation—Changes and Challenges

    Article • American Journal of Transplantation, April 2012, Elsevier

    Professor Jøran Hjelmesæth

  26. Vitamin status after gastric bypass and lifestyle intervention: a comparative prospective study

    Article • Surgery for Obesity and Related Diseases, March 2012, Elsevier

    Professor Jøran Hjelmesæth

  27. Comment on: Chakkera et al. Pretransplant Risk Score for New-Onset Diabetes After Kidney Transplantation. Diabetes Care 2011;34:2141–2145

    Article • Diabetes Care, February 2012, American Diabetes Association

    Professor Jøran Hjelmesæth

  28. Om fedme på dansk

    Article • Tidsskrift for Den norske legeforening, January 2012, Norwegian Medical Association

    Professor Jøran Hjelmesæth

  29. Overvekt hos barn - et bygdeproblem?

    Article • Tidsskrift for Den norske legeforening, January 2012, Norwegian Medical Association

    Professor Jøran Hjelmesæth

  30. Nyresvikt, fedme og kosthold

    Article • Tidsskrift for Den norske legeforening, January 2012, Norwegian Medical Association

    Professor Jøran Hjelmesæth

  31. Om gener og fedme - alt er ikke din skyld!

    Article • Tidsskrift for Den norske legeforening, January 2012, Norwegian Medical Association

    Professor Jøran Hjelmesæth

  32. Viktig bok om overvekt hos barn og unge

    Article • Tidsskrift for Den norske legeforening, January 2012, Norwegian Medical Association

    Professor Jøran Hjelmesæth

  33. Impact of gender on vitamin D deficiency in morbidly obese patients: a cross-sectional study

    Article • European Journal of Clinical Nutrition, July 2011, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  34. The association of early post-transplant glucose levels with long-term mortality

    Article • Diabetologia, March 2011, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  35. Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention

    Article • European Journal of Endocrinology, February 2011, Bioscientifica

    Professor Jøran Hjelmesæth

  36. The relationship between various measures of obesity and arterial stiffness in morbidly obese patients

    Article • BMC Cardiovascular Disorders, February 2011, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  37. Fedmekirurgi for ungdom?

    Article • Tidsskrift for Den norske legeforening, January 2011, Norwegian Medical Association

    Professor Jøran Hjelmesæth

  38. Tung lærebok om fedme

    Article • Tidsskrift for Den norske legeforening, January 2011, Norwegian Medical Association

    Professor Jøran Hjelmesæth

  39. God bok om endring av helseatferd

    Article • Tidsskrift for Den norske legeforening, January 2011, Norwegian Medical Association

    Professor Jøran Hjelmesæth

  40. Validity of the SF-36 in Patients with Morbid Obesity

    Article • Obesity Facts, January 2011, Karger Publishers

    Professor Jøran Hjelmesæth

  41. Oppfølging etter fedmekirurgi

    Article • Tidsskrift for Den norske legeforening, January 2011, Norwegian Medical Association

    Professor Jøran Hjelmesæth

  42. Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study

    Article • Cardiovascular Diabetology, January 2011, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  43. Type 2 diabetes and pre-diabetes are associated with obstructive sleep apnea in extremely obese subjects: A cross-sectional study

    Article • Cardiovascular Diabetology, January 2011, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  44. The effect of tobacco smoking and treatment strategy on the one-year mortality of patients with acute non-ST-segment elevation myocardial infarction

    Article • BMC Cardiovascular Disorders, December 2010, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  45. The Relationship Between Anthropometric Measures, Blood Gases, and Lung Function in Morbidly Obese White Subjects

    Article • Obesity Surgery, November 2010, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  46. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention

    Article • European Journal of Endocrinology, November 2010, Bioscientifica

    Professor Jøran Hjelmesæth

  47. Employment Is Associated with the Health-Related Quality of Life of Morbidly Obese Persons

    Article • Obesity Surgery, October 2010, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  48. Significant Increase in Systemic Exposure of Atorvastatin After Biliopancreatic Diversion With Duodenal Switch

    Article • Clinical Pharmacology & Therapeutics, May 2010, Wiley

    Professor Jøran Hjelmesæth

  49. Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study

    Article • BMC Endocrine Disorders, April 2010, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  50. Undiagnosed Diabetes in Kidney Transplant Candidates

    Article • Clinical Journal of the American Society of Nephrology, April 2010, Wolters Kluwer Health

    Professor Jøran Hjelmesæth

  51. Comparison of vitamin concentrations after gastric bypass and lifestyle intervention

    Article • Surgery for Obesity and Related Diseases, March 2010, Elsevier

    Professor Jøran Hjelmesæth

  52. Morbidly Obese Patients—Who Undergoes Bariatric Surgery?

    Article • Obesity Surgery, January 2010, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  53. Sykelig overvekt – ulikt behandlingstilbud

    Article • Tidsskrift for Den norske legeforening, January 2010, Norwegian Medical Association

    Professor Jøran Hjelmesæth

  54. Plasma 25-Hydroxyvitamin D Concentration and Metabolic Syndrome Among Middle-Aged and Elderly Chinese Individuals

    Article • Diabetes Care, January 2010, American Diabetes Association

    Professor Jøran Hjelmesæth

  55. Effect of Implementing Routine Early Invasive Strategy on One-Year Mortality in Patients With Acute Myocardial Infarction

    Article • The American Journal of Cardiology, January 2010, Elsevier

    Professor Jøran Hjelmesæth

  56. Fasting Plasma Glucose in the Screening for Type 2 Diabetes in Morbidly Obese Subjects

    Article • Obesity Surgery, December 2009, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  57. Glucose tolerance before and after renal transplantation

    Article • Nephrology Dialysis Transplantation, October 2009, Oxford University Press (OUP)

    Professor Jøran Hjelmesæth

  58. Anthropometric characteristics and type 2 diabetes in extremely obese Caucasian subjects: A cross-sectional study

    Article • Diabetes Research and Clinical Practice, October 2009, Elsevier

    Professor Jøran Hjelmesæth

  59. Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose

    Article • European Journal of Endocrinology, September 2009, Bioscientifica

    Professor Jøran Hjelmesæth

  60. Fasting Plasma Glucose and Glycosylated Hemoglobin in the Screening for Diabetes Mellitus After Renal Transplantation

    Article • Transplantation, August 2009, Wolters Kluwer Health

    Professor Jøran Hjelmesæth

  61. Significantly Altered Systemic Exposure to Atorvastatin Acid Following Gastric Bypass Surgery in Morbidly Obese Patients

    Article • Clinical Pharmacology & Therapeutics, June 2009, Wiley

    Professor Jøran Hjelmesæth

  62. Alternativ behandling av fedme

    Article • Tidsskrift for Den norske legeforening, January 2009, Norwegian Medical Association

    Professor Jøran Hjelmesæth

  63. Fedmeepidemien – vi må begynne med barna

    Article • Tidsskrift for Den norske legeforening, January 2009, Norwegian Medical Association

    Professor Jøran Hjelmesæth

  64. Fedmebehandling på svensk – atferdsendring i praksis?

    Article • Tidsskrift for Den norske legeforening, January 2009, Norwegian Medical Association

    Professor Jøran Hjelmesæth

  65. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study

    Article • Cardiovascular Diabetology, January 2009, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  66. Endothelial Function in Renal Transplant Recipients is Associated with Circulating Nitric Oxide, ACE Inhibitor Use and Time After Transplantation

    Article • Vascular Disease Prevention, December 2008, Bentham Science Publishers

    Professor Jøran Hjelmesæth

  67. Role of Prednisolone Pharmacokinetics in Postchallenge Glycemia After Renal Transplantation

    Article • Therapeutic Drug Monitoring, October 2008, Wolters Kluwer Health

    Professor Jøran Hjelmesæth

  68. Peripheral Neuropathy and Severe Malnutrition following Duodenal Switch

    Article • Obesity Surgery, May 2008, Springer Science + Business Media

    Professor Jøran Hjelmesæth

  69. Ghrelin, Atherosclerosis, and Glucose: GAG or Causal Relationships?

    Article • Transplantation, November 2007, Wolters Kluwer Health

    Professor Jøran Hjelmesæth

  70. Reduced Incidence of New-Onset Posttransplantation Diabetes Mellitus During the Last Decade

    Article • Transplantation, November 2007, Wolters Kluwer Health

    Professor Jøran Hjelmesæth

  71. Reply

    Article • Nephrology Dialysis Transplantation, June 2007, Oxford University Press (OUP)

    Professor Jøran Hjelmesæth

  72. The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man

    Article • Nephrology Dialysis Transplantation, March 2007, Oxford University Press (OUP)

    Professor Jøran Hjelmesæth

  73. Nateglinide improves postprandial hyperglycemia and insulin secretion in renal transplant recipients

    Article • Clinical Transplantation, March 2007, Wiley

    Professor Jøran Hjelmesæth

  74. Endothelial Function in Renal Transplant Recipients is Associated with Circulating Nitric Oxide, ACE Inhibitor Use and Time After Transplantation

    Article • Vascular Disease Prevention, August 2006, Bentham Science Publishers

    Professor Jøran Hjelmesæth

  75. Early Posttransplant Serum Osteoprotegerin Levels Predict Long-Term (8-Year) Patient Survival and Cardiovascular Death in Renal Transplant Patients

    Article • Journal of the American Society of Nephrology, June 2006, Wolters Kluwer Health

    Professor Jøran Hjelmesæth

  76. Hypoadiponectinemia Is Associated with Insulin Resistance and Glucose Intolerance after Renal Transplantation

    Article • Clinical Journal of the American Society of Nephrology, May 2006, Wolters Kluwer Health

    Professor Jøran Hjelmesæth

  77. Association between insulin resistance and endothelial dysfunction in renal transplant recipients

    Article • Clinical Transplantation, February 2006, Wiley

    Professor Jøran Hjelmesæth

  78. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events

    Article • Kidney International, February 2006, Elsevier

    Professor Jøran Hjelmesæth

  79. High mortality rates in conservatively managed patients with acute coronary syndrome

    Article • Scandinavian Cardiovascular Journal, January 2006, Taylor & Francis

    Professor Jøran Hjelmesæth

  80. Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced  -cell damage

    Article • Nephrology Dialysis Transplantation, September 2005, Oxford University Press (OUP)

    Professor Jøran Hjelmesæth

  81. Reply

    Article • Nephrology Dialysis Transplantation, April 2005, Oxford University Press (OUP)

    Professor Jøran Hjelmesæth

  82. New-Onset Posttransplantation Diabetes Mellitus: Insulin Resistance or Insulinopenia? Impact of Immunosuppressive Drugs, Cytomegalovirus and Hepatitis C Virus Infection

    Article • Current Diabetes Reviews, January 2005, Bentham Science Publishers

    Professor Jøran Hjelmesæth

  83. Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients

    Article • Nephrology Dialysis Transplantation, December 2004, Oxford University Press (OUP)

    Professor Jøran Hjelmesæth

  84. Determinants of insulin secretion after renal transplantation

    Article • Metabolism, May 2003, Elsevier

    Professor Jøran Hjelmesæth

  85. The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation*

    Article • Clinical Transplantation, November 2002, Wiley

    Professor Jøran Hjelmesæth

  86. Response to Montori et al.

    Article • Diabetes Care, September 2002, American Diabetes Association

    Professor Jøran Hjelmesæth

  87. Insulin Resistance After Renal Transplantation

    Article • Diabetes Care, July 2002, American Diabetes Association

    Professor Jøran Hjelmesæth

  88. Losartan for cardiovascular disease in patients with and without diabetes in the LIFE study

    Article • The Lancet, June 2002, Elsevier

    Professor Jøran Hjelmesæth

  89. Risk for posttransplant diabetes mellitus with current immunosuppressive medications

    Article • American Journal of Kidney Diseases, March 2000, Elsevier

    Professor Jøran Hjelmesæth

  90. Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients.

    Article • Nephrology Dialysis Transplantation, February 1998, Oxford University Press (OUP)

    Professor Jøran Hjelmesæth